Company: SVREW
Filing Date: 2025-03-21
Form Type: 20-F
Source: 0001013762-25-001028
Chunk: 151

Company: SaverOne 2014 Ltd.
Filing Date: 2025-03-21
Form: 20-F
Item: Item 19
Chunk 151
---
 and equipment  

Property
and equipment items are presented at cost, less accumulated depreciation and net of accrued impairment losses, if any. Cost includes,
in addition to the acquisition cost, all of the costs that can be directly attributed to the bringing of the item to the location and
condition necessary for the item to operate in accordance with the intentions of management.

Depreciation
is calculated using the straight-line method over the estimated useful lives of the fixed asset items or of a discernible component.

The
annual depreciation rates are as follows:

                               %                                                                                 
  Computers                    20 - 33                                                                           
  Office                       6 - 7                                                                             
  Leasehold                    The shorter of the contract period or the life span of the leasehold improvement  

  Impairment of non-monetary assets  

Non-monetary
depreciable assets are tested for possible impairment in value when events or circumstances occur that may indicate that the carrying
value of the given asset is not recoverable. When the carrying value of an asset in the statement of financial position exceeds its recoverable
value, the Company recognizes an impairment loss in an amount equal to the difference between the carrying value of the asset and its
recoverable value, which is the higher of its fair value less selling costs and its value in use (the present value of the estimated
future cash flows expected to derive from the use and realization of the asset). For purposes of assessing a decline in value, the assets
are allocated to the lowest possible level in respect of which there are separate identifiable cash flows (cash-generating units).

F-13

SAVERONE
2014 LTD.

NOTES
TO THE FINANCIAL STATEMENTS (CONT.)

(New
Israeli Shekels in thousands, except per share and share data)

Note
2 - Material accounting policies (Cont.)

  Research and development expenses  

Research
costs are expensed when incurred. Development expenses are capitalized and recognized as an asset, commencing the phase in which technological
feasibility is achieved, when the company has intentions and the capabilities to complete and use (or sell) the asset, it is probable
that the developed asset will generate future economic benefits and the development costs are attributable in a reliable manner.

The
amortization of the intangible asset commences when the asset becomes ready for its intended use.

An
expense in respect of development that does not meet the conditions required to be recognized as an asset, as above, is carried to profit
and loss when incurred.

As
of